Bret Wood v. HHS - Tdap, myelin oligodendrocyte glycoprotein antibody disease (MOGAD) and transverse myelitis (2026)

On February 25, 2022, Bret Wood filed a petition alleging that a Tdap vaccination administered on March 20, 2020 caused myelin oligodendrocyte glycoprotein antibody disease and transverse myelitis. Respondent denied that the Tdap vaccine, a tetanus-toxoid-containing vaccine, or any other covered vaccine caused or significantly aggravated Mr.

Wood's MOGAD, transverse myelitis, or any other injury. The public stipulation does not describe the first neurologic symptom, diagnostic testing, hospitalization, steroid or plasma treatment, rehabilitation, or residual limitations.

The parties resolved the case by stipulation. On January 12, 2026, Special Master Nora Beth Dorsey adopted the stipulation and awarded Mr.

Wood $70,000.00 as a lump sum for all damages available under the Vaccine Act.